Tops & Flops Stocks
| Security | Change (%) ▼ | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ardelyx Inc. | 28.120% | 34.723% | 18.969% | 89.624% | 39.758% | 44.250% | - |
| Avenue Therapeutics Inc. | 22.820% | - | - | - | - | - | - |
| F-Star Therapeutics Inc. | 18.750% | - | - | - | - | - | - |
| G1 Therapeutics | 17.910% | 14.761% | -3.138% | 50.949% | 50.400% | -76.051% | - |
| Codexis Inc. | 16.890% | 47.016% | 18.377% | -1.699% | 29.108% | -80.398% | -79.934% |
| Omeros Corp. | 16.720% | 17.688% | 19.247% | -22.624% | 9.126% | -76.454% | -79.689% |
| Abeona Therapeutics Inc. | 15.790% | 39.869% | -38.417% | 52.530% | -9.130% | -89.803% | - |
| Ziopharm Oncology | 11.930% | - | - | - | - | - | - |
| Salarius Pharmaceuticals Inc. | 11.650% | 7.981% | 17.949% | -67.606% | -17.117% | -98.248% | -99.993% |
| Organovo Holdings Inc. | 10.940% | 2.872% | 1.363% | -43.118% | -5.750% | -85.556% | -94.698% |
| BioScrip Inc. | 9.810% | - | - | - | - | - | - |
| Lexicon Pharmaceuticals Inc. | 9.690% | 8.772% | -14.619% | -35.520% | 16.812% | -59.780% | -72.317% |
| Alimera Sciences | 9.190% | - | - | - | - | - | - |
| AnaptysBio Inc | 8.770% | 27.179% | 31.217% | 29.167% | 27.835% | 27.835% | - |
| Infinity Pharmaceuticals Inc. | 7.360% | - | - | - | - | - | - |
| Athersys Inc. | 6.990% | - | - | - | - | - | - |
| Regenxbio Inc | 6.900% | 3.333% | -17.112% | -12.429% | -7.186% | -45.690% | - |
| Seaspine Holdings Corp | 6.670% | - | - | - | - | - | - |
| Ocular Therapeutix Inc. | 6.400% | 29.154% | -26.621% | 2.377% | 36.511% | -61.297% | 75.275% |
| XBiotech Inc | 6.340% | 0.000% | -6.790% | 138.924% | 113.277% | -45.917% | -7.555% |
| Madrigal Pharmaceuticals inc. | 5.910% | 18.008% | -5.828% | -22.689% | 0.899% | 87.105% | 129.207% |
| Allscripts Healthcare | 5.800% | 5.797% | 12.308% | -32.407% | -21.081% | -44.697% | -16.227% |
| Akebia Therapeutics Inc. | 5.260% | 2.324% | -6.856% | 59.625% | 8.959% | -51.629% | - |
| Caredx Inc | 5.250% | 27.959% | -2.382% | 16.335% | -22.276% | -86.339% | - |
| Eidos Therapeutics | 5.050% | - | - | - | - | - | - |